Methods for treating renal cell carcinoma

Details for Australian Patent Application No. 2006207987 (hide)

Owner Novartis Vaccines and Diagnostics Inc.

Inventors Elias, Laurence; Witherell, Gary

Agent FB Rice

Pub. Number AU-B-2006207987

PCT Pub. Number WO2006/081510

Priority 60/647,496 27.01.05 US

Filing date 27 January 2006

Wipo publication date 3 August 2006

Acceptance publication date 15 September 2011

International Classifications

A61K 38/20 (2006.01) Medicinal preparations containing peptides - Interleukins

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/04 (2006.01) Antineoplastic agents

Event Publications

23 August 2007 PCT application entered the National Phase

  PCT publication WO2006/081510 Priority application(s): WO2006/081510

15 September 2011 Application Accepted

  Published as AU-B-2006207987

19 January 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006207990-Image transfer media and methods of using the same

2006207977-Controlled release of additive gel(s) for functional fluids